N/A
N=104
Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale
Erythema · Rosacea
Bottom Line
View on ClinicalTrials.gov: NCT01636765 ↗Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Nov 2013
Primary outcome: Primary: Inter-rater Reliability of the Clinician Erythema Assessment (CEA) Scale — 0.908 Kendall's W
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- No Intervention (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- Jul 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Inter-rater Reliability of the Clinician Erythema Assessment (CEA) Scale |
0.908 | — |
| PRIMARY Intra-rater Reliability of the CEA Scale |
0.752 | — |
Summary
This is a study to evaluate inter- and intra-rater reliability of the Clinician Erythema Assessment Scale. There is no treatment (intervention) associated with this study.
Eligibility Criteria
Inclusion Criteria
- Rosacea
Exclusion Criteria
- Unwilling to remove all facial make-up
Data sourced from ClinicalTrials.gov (NCT01636765). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.